DK3774844T3 - Krystallinske dipeptider, der er anvendelige i syntese af elamipretid - Google Patents

Krystallinske dipeptider, der er anvendelige i syntese af elamipretid Download PDF

Info

Publication number
DK3774844T3
DK3774844T3 DK19781432.0T DK19781432T DK3774844T3 DK 3774844 T3 DK3774844 T3 DK 3774844T3 DK 19781432 T DK19781432 T DK 19781432T DK 3774844 T3 DK3774844 T3 DK 3774844T3
Authority
DK
Denmark
Prior art keywords
elamipretide
crystalline
synthesis
dipeptides
useful
Prior art date
Application number
DK19781432.0T
Other languages
Danish (da)
English (en)
Inventor
Scott M Duncan
Martin P Redmon
Original Assignee
Stealth Biotherapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stealth Biotherapeutics Inc filed Critical Stealth Biotherapeutics Inc
Application granted granted Critical
Publication of DK3774844T3 publication Critical patent/DK3774844T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06086Dipeptides with the first amino acid being basic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/20Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06086Dipeptides with the first amino acid being basic
    • C07K5/06095Arg-amino acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1019Tetrapeptides with the first amino acid being basic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2299/00Coordinates from 3D structures of peptides, e.g. proteins or enzymes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK19781432.0T 2018-04-02 2019-03-28 Krystallinske dipeptider, der er anvendelige i syntese af elamipretid DK3774844T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862651430P 2018-04-02 2018-04-02
PCT/US2019/024617 WO2019195080A1 (en) 2018-04-02 2019-03-28 Crystalline dipeptides useful in the synthesis of elamipretide

Publications (1)

Publication Number Publication Date
DK3774844T3 true DK3774844T3 (da) 2023-04-03

Family

ID=68101313

Family Applications (1)

Application Number Title Priority Date Filing Date
DK19781432.0T DK3774844T3 (da) 2018-04-02 2019-03-28 Krystallinske dipeptider, der er anvendelige i syntese af elamipretid

Country Status (13)

Country Link
US (4) US10975118B2 (https=)
EP (2) EP3774844B1 (https=)
JP (2) JP7350007B2 (https=)
KR (2) KR102753323B1 (https=)
CN (2) CN112292388B (https=)
AU (1) AU2019249121B2 (https=)
CA (2) CA3280578A1 (https=)
DK (1) DK3774844T3 (https=)
ES (1) ES2941266T3 (https=)
FI (1) FI3774844T3 (https=)
IL (2) IL315355A (https=)
PT (1) PT3774844T (https=)
WO (1) WO2019195080A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115160402A (zh) * 2016-03-11 2022-10-11 隐形生物治疗公司 结晶盐形式
PT3774844T (pt) 2018-04-02 2023-03-28 Stealth Biotherapeutics Inc Dipeptídeos cristalinos úteis na síntese de elamipretida
CN117881411A (zh) 2021-06-01 2024-04-12 艾迪雅生物有限责任公司 用于眼部药物的延长释放药物递送系统和使用方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4711166B2 (ja) * 2004-08-03 2011-06-29 株式会社 液晶先端技術開発センター 結晶化装置、および結晶化方法
CA3022250A1 (en) * 2012-12-12 2014-06-12 Ariad Pharmaceuticals, Inc. Crystalline forms of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-n-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide mono hydrochloride
CN104945453B (zh) * 2014-03-28 2018-06-26 江苏天士力帝益药业有限公司 吡唑衍生物的多晶型物
WO2016001042A1 (en) 2014-06-30 2016-01-07 Flamma S.P.A. Process for the production of d-arginyl-2,6-dimethyl-l-tyrosyl-l-lysyl-l-phenylalaninamide
US10633415B2 (en) * 2015-03-06 2020-04-28 Stealth Biotherapeutics Corp Processes for preparing pharmaceutically relevant peptides
CA3254279A1 (en) * 2015-06-03 2025-03-18 Triastek, Inc. PHARMACEUTICAL FORMS AND RELATED USES
CN115160402A (zh) * 2016-03-11 2022-10-11 隐形生物治疗公司 结晶盐形式
CN110087667A (zh) 2016-08-16 2019-08-02 隐形生物治疗公司 Elamipretide的基于N-羧基酸酐的规模合成
CN110914287A (zh) * 2017-04-05 2020-03-24 隐形生物治疗公司 Boc-d-arg-dmt-lys-(boc)-phe-nh2的结晶盐形式
PT3774844T (pt) 2018-04-02 2023-03-28 Stealth Biotherapeutics Inc Dipeptídeos cristalinos úteis na síntese de elamipretida

Also Published As

Publication number Publication date
US20250122238A1 (en) 2025-04-17
AU2019249121B2 (en) 2024-05-02
CA3280578A1 (en) 2025-10-30
AU2019249121A1 (en) 2020-11-26
EP3774844A1 (en) 2021-02-17
KR102753323B1 (ko) 2025-01-09
IL315355A (en) 2024-11-01
EP4219523A3 (en) 2023-08-09
IL277718B1 (en) 2024-10-01
ES2941266T3 (es) 2023-05-19
US20200283476A1 (en) 2020-09-10
KR20210005042A (ko) 2021-01-13
EP4219523A2 (en) 2023-08-02
CN112292388B (zh) 2024-04-19
EP3774844A4 (en) 2021-12-15
US12018094B2 (en) 2024-06-25
JP2021520357A (ja) 2021-08-19
CA3095869C (en) 2025-10-21
CN118206614A (zh) 2024-06-18
JP7663642B2 (ja) 2025-04-16
EP3774844B1 (en) 2023-02-22
JP2023165756A (ja) 2023-11-17
PT3774844T (pt) 2023-03-28
CN112292388A (zh) 2021-01-29
JP7350007B2 (ja) 2023-09-25
KR20250010134A (ko) 2025-01-20
IL277718B2 (en) 2025-02-01
US20210292274A1 (en) 2021-09-23
FI3774844T3 (fi) 2023-04-04
IL277718A (en) 2020-11-30
US11560404B2 (en) 2023-01-24
US10975118B2 (en) 2021-04-13
CA3095869A1 (en) 2019-10-10
WO2019195080A1 (en) 2019-10-10
US20230203093A1 (en) 2023-06-29

Similar Documents

Publication Publication Date Title
DK3810581T3 (da) Krystalmodifikationer af odevixibat
IL268852A (en) Crystalline forms of the 4-pyrimidinesulfamide derivative aprocitentan
DK3382551T3 (da) Sporing af fordelt hardware
LT3768674T (lt) Aminopirimidino dariniai kaip ctps1 inhibitoriai
IL286218A (en) Solid state forms of ripretinib
EP3853332C0 (en) COMPOSITION
EP3647317A4 (en) FUNCTIONAL CRYSTALLINE SWEETENER
DK3833662T3 (da) Inhibitorer af protein-protein-interaktionen mellem KEAP-1-NRF2-
EP3885442A4 (en) NOVEL KETOSE-3-EPIMERASE
EP3882323A4 (en) COMPOSITION
DK3793970T3 (da) Fremgangsmåde til syntetisering af methanol
DK3840596T3 (da) Sammensætning
DK4101454T3 (da) Sammensætninger til behandling af hypertension
EP3812426A4 (en) CURABLE COMPOSITION
DK3818059T3 (da) Mellemprodukter i syntese af c3-substituerede cephalosporiner
DK3844162T3 (da) Hæmmere af alfa-v-beta6-integrin
DK3823970T3 (da) Yderligere substituerede triazoloquinoxalinderivater
EP3829551C0 (en) CRYSTALLINE EPINEPHRINE MALONATE SALT
DK3823971T3 (da) Substituerede triazol-quinoxalin-derivater
DK3850113T3 (da) Markører, der er nyttige i berigelsesstrategier til behandling af slidgigt
DK3774844T3 (da) Krystallinske dipeptider, der er anvendelige i syntese af elamipretid
DK3749673T3 (da) Krystallinsk form af bictegravir-natrium
DK3630725T3 (da) Krystallinsk form af n-butyldeoxygalactonojirimycin
DK3894410T3 (da) Substituerede xanthinderivater
DK3774751T3 (da) Co-krystaller